Depo Provera Lawsuit: Tumor Claims

Depo Provera has been linked to a 5.5× higher risk of developing meningioma brain tumors.

Quick Facts About Depo Provera Lawsuit

If you or a loved one received Depo Provera birth control shots and developed a brain tumor, you may qualify for substantial compensation.

  • Key Statistics & Case Status: A 2024 British Medical Journal study of French National Health Data (108,000 women) found Depo Provera users face a 5.55-fold increased odds of developing meningioma versus non-users
  • MDL No. 3140 Status: All Depo Provera lawsuits (meningioma) have been centralized in U.S. District Court for the Northern District of Florida as MDL No. 3140
  • Prescription Volume: Over 20 million women worldwide have received Depo Provera injections since its market launch.

FREE Depo Provera CASE REVIEW

CALL NOW:  1-866-374-0338

Do You Qualify for a Depo Provera Brain Tumor Lawsuit?

Medical Criteria

Most claimants meet at least one of the following:

  • 12+ months of Depo Provera use (any time since 1992)
  • Meningioma diagnosis confirmed by MRI or surgical pathology
  • Brain tumor surgery performed or ongoing neurosurgical monitoring
  • Neurological symptoms (headaches, seizures, vision changes, cognitive decline)
  • No prior brain-tumor history before Depo Provera
  • Willing to share records, including MRI scans and pathology slides

Preferred Documentation

If you don’t yet have these, our team can help you secure them

  • Depo Provera injection logs (pharmacy/clinic records)
  • MRI reports & surgical pathology slides
  • Neurosurgeon or neurologist consultation notes.
  • Hospital and imaging-center billing statements.
  • Personal medical timeline of symptom onset and treatment dates.

Not sure if you have all the records? Get a free case review →

Have You Experienced These Symptoms?

Blurry or distorted vision
Persistent or worsening headaches
Night blindness
Seizures or convulsions
Muted or faded colors
Blurred, double, or partial vision loss
Difficulty reading
Memory lapses or cognitive decline
Trouble seeing street signs or traffic lights
Hearing loss or ringing in the ears
Light sensitivity or halos around lights
Balance problems or limb weakness
Not sure? Get a free case review →

ALERT: Untreated or undiagnosed meningiomas can grow and cause permanent neurological damage. Act now to protect your rights.

Depo Provera Lawsuit MDL Timeline

From FDA approval through MDL consolidation, here are the key milestones in the Depo Provera Lawsuit (meningioma) litigation.

1992

1992 – FDA approves Depo Provera

Medroxyprogesterone acetate (Depo Provera) is approved as a long-acting contraceptive injection.
FDA approval
2014

2014 – First Depo Provera lawsuits filed

Plaintiffs begin filing failure-to-warn claims linking Depo Provera use to meningioma brain tumors.
2024

2024 – Landmark BMJ study reports 5.55× higher meningioma risk

Roland N et al. publish a nationwide nested case-control study in the British Medical Journal, finding a 5.55-fold higher meningioma risk in women using Depo Provera for ≥1 year
BMJ study (Roland N et al., 2024)
2025

Feb 2025 – MDL 3140 centralized in northern Florida

The U.S. Judicial Panel on Multidistrict Litigation forms MDL No. 3140 in the Northern District of Florida, consolidating all Depo Provera lawsuits (meningioma).
JPML centralization order (MDL No. 3140)

Harmed by Depo Provera?

Get answers. Get help. Start your free brain-tumor case review.

Call Now!
1-866-374-0338

or

Get Started!
Request a callback online

With over 30 years of experience and more than $100 million recovered, The Johnson Law Firm has stood up to major drug manufacturers and won. We’re proud to represent clients across the U.S. in high-stakes litigation involving defective medications.

Real Results From Real Clients

“I was amazed with the results that JLF achieved for me.  I wasn’t expecting anything like that, but it was just awesome.  They just went to bat for me and accomplished quite a bit.  I was just really blown away by the results.”
— Julie

Pregnant woman discussing ultrasound results with doctor during Depo-Provera lawsuit evaluation

How a Depo Provera Brain Tumor Lawsuit Works

Depo Provera (medroxyprogesterone acetate) was approved in 1992, but a landmark 2024 BMJ study and other medical research have shown long-term users face a significantly higher risk of developing meningioma brain tumors. When drug makers fail to update warnings or downplay emerging science, they can be held liable under various product-liability theories.

  • Signal Detection: A nationwide nested case-control study published in the British Medical Journal (Roland et al., 2024) analyzed over 108,000 women and found a 5.55-fold increased risk of meningioma in Depo Provera users.
  • Case Consolidation: All federal Depo Provera lawsuits (meningioma) were centralized in MDL No. 3140 (N.D. Fla.) in February 2025, streamlining pretrial discovery and preserving each patient’s unique story.
  • Causation Proof: Neurologists, neurosurgeons, and onco-pathologists testify to the hormone-driven growth mechanism of meningiomas, supported by NIH endocrinology research on synthetic progestins.
  • Compensation: Covers past/future medical treatment, lost income, diminished quality of life, and, in some states, punitive damages for reckless conduct.
  • Liability Theories: Failure-to-warn, design defect, and negligent marketing claims.

Results-Driven Representation: Our team will marshal the latest science, review your medical records at no cost, and fight for the maximum compensation you deserve.

How We Help Elmiron Victims

At The Johnson Law Firm, we take a strategic, compassionate approach to every Depo Provera brain-tumor case. Our goal is to uncover the full truth, hold negligent drug makers accountable, and secure maximum compensation for the harm you’ve endured.

Our Process:

  • Free MRI & Pathology Report Review: We analyze your MRI scans, surgical pathology reports, and neurologist notes at no cost to confirm meningioma and link it to Depo Provera exposure.
  • Medical Expert Network: We engage board-certified neurologists, neurosurgeons, and neuro-oncologists to testify on your behalf and explain the hormone-driven tumor biology.
  • Scientific & Regulatory Analysis: Our team documents how Pfizer and other manufacturers failed to update warnings after pivotal studies (e.g., Roland et al., BMJ 2024) confirmed a 5.55× increased meningioma risk.
  • Coordinated MDL Litigation: We handle your claim in MDL No. 3140 (N.D. Fla.) or the strongest state court, managing discovery and preserving your individual story.
  • Contingency-Fee Promise: You owe us nothing unless we win compensation for your medical expenses, lost income, pain & suffering, and—where allowed—punitive damages.

Results-Driven Representation: Focus on your health while we fight for maximum recovery.

Depo Provera Brain Tumor FAQs

A Depo Provera lawsuit (meningioma) is a legal claim on behalf of women who developed benign or malignant meningioma brain tumors after using the injectable contraceptive Depo Provera. It seeks compensation for medical bills, lost wages, pain and suffering, and other damages.

A 2024 British Medical Journal study of over 108,000 women found that users of medroxyprogesterone acetate (Depo-Provera®) for one year or longer face a 5.55-fold increased risk of meningioma compared to non-users.

Common warning signs include:

  • Chronic or worsening headaches
  • New vision changes (blurriness, double vision)
  • Seizures or convulsions
  • Cognitive or memory impairment
  • Balance, hearing issues, or light sensitivity

If you’ve experienced any of these after Depo Provera use, contact us immediately.

Most claimants meet all of the following:

  • Received Depo Provera injections for at least one year (any time since 1992)
  • Diagnosed with a meningioma via MRI or surgical pathology
  • No pre-existing brain tumor prior to Depo Provera use

Our team can help verify your eligibility

Key evidence includes your Depo Provera injection records, MRI reports confirming a meningioma diagnosis, neurosurgical or pathology notes, and any related treatment documents.

Yes. On February 7, 2025, the Judicial Panel on Multidistrict Litigation centralized all federal Depo-Provera® meningioma claims in MDL No. 3140 (U.S. District Court, Northern District of Florida).

We handle these cases on a contingency-fee basis – no fees unless we recover compensation for you. You pay nothing up front.

Victims may recover medical expenses, surgical costs, rehabilitation, lost wages, pain and suffering, and in some cases punitive damages for egregious misconduct.

Ready for your free Depo Provera brain-tumor case review?

Our attorneys will review your medical history and MRI or pathology reports at no cost.

Trusted nationwide. Thousands of clients. Millions recovered. No fees unless we win.

Ribbon Award Icon

35+ Years of Experience

Since 1993, trusted nationwide
Ribbon Award Icon

$100M+ Recovered to Clients

Product liability & mass torts
Ribbon Award Icon

No Fees Unless We Win

You pay nothing upfront
Ribbon Award Icon

Nationwide Representation

Clients in all 50 states